NDC 47335-890 – Temozolomide
Temozolomide 5 mg/1 · Capsule · Oral
Product NDC47335-890
Product details
- Brand name
- Temozolomide
- Generic name
- Temozolomide
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA201742
- Marketed since
- February 13, 2014
- Listing expires
- December 31, 2026
- Pharmacologic class
- Alkylating Drug
Active ingredients
- Temozolomide 5 mg/1
Package NDC codes (6)
| Package NDC | Description | Since |
|---|---|---|
| 47335-890-21 | 1 BOTTLE in 1 CARTON (47335-890-21) / 14 CAPSULE in 1 BOTTLE | Feb 13, 2014 |
| 47335-890-72 | 15 BLISTER PACK in 1 CARTON (47335-890-72) / 1 CAPSULE in 1 BLISTER PACK | Feb 13, 2014 |
| 47335-890-74 | 5 BLISTER PACK in 1 CARTON (47335-890-74) / 1 CAPSULE in 1 BLISTER PACK | Feb 13, 2014 |
| 47335-890-75 | 20 BLISTER PACK in 1 CARTON (47335-890-75) / 1 CAPSULE in 1 BLISTER PACK | Feb 13, 2014 |
| 47335-890-80 | 1 BOTTLE in 1 CARTON (47335-890-80) / 5 CAPSULE in 1 BOTTLE | Feb 13, 2014 |
| 47335-890-87 | 1 BOTTLE in 1 CARTON (47335-890-87) / 20 CAPSULE in 1 BOTTLE | Feb 13, 2014 |
Other Temozolomide products
- 16729-048 Temozolomide 5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-049 Temozolomide 20 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-050 Temozolomide 100 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-051 Temozolomide 250 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-129 Temozolomide 140 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-130 Temozolomide 180 mg/1 · Capsule · Accord Healthcare Inc.
- 65162-802 Temozolomide 20 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-801 Temozolomide 5 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-806 Temozolomide 250 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-804 Temozolomide 140 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-805 Temozolomide 180 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-803 Temozolomide 100 mg/1 · Capsule · Amneal Pharmaceuticals LLC